| ACKR3 |
P25106
|
atypical chemokine receptor 3
|
G-protein coupled receptor
|
0.39 |
0.428 |
0.885 |
| ACTB |
P60709
|
actin beta
|
Cellular structure
|
0.99 |
0.325 |
0.923 |
| AKT1 |
P31749
|
AKT serine/threonine kinase 1
|
Kinase
|
0.98 |
0.311 |
0.962 |
| ARHGAP24 |
Q8N264
|
Rho GTPase activating protein 24
|
|
3.9E-10 |
0.456 |
0.808 |
| B2M |
P61769
|
beta-2-microglobulin
|
Immune response
|
0.56 |
0.447 |
0.846 |
| B3GAT1 |
Q9P2W7
|
beta-1,3-glucuronyltransferase 1
|
Enzyme
|
0.14 |
0.494 |
0.769 |
| BAP1 |
Q92560
|
BRCA1 associated protein 1
|
Enzyme
|
0.99 |
0.454 |
0.731 |
| BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
| BMP7 |
P18075
|
bone morphogenetic protein 7
|
Signaling
|
0.13 |
0.498 |
0.769 |
| BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
| CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |
| CCL2 |
P13500
|
C-C motif chemokine ligand 2
|
Signaling
|
0.61 |
0.321 |
0.962 |
| CCR7 |
P32248
|
C-C motif chemokine receptor 7
|
G-protein coupled receptor
|
5.8E-02 |
0.443 |
0.769 |
| CD160 |
O95971
|
CD160 molecule
|
|
6.8E-05 |
0.590 |
0.615 |
| CD163 |
Q86VB7
|
CD163 molecule
|
Enzyme
|
8.3E-04 |
0.427 |
0.846 |
| CD274 |
Q9NZQ7
|
CD274 molecule
|
Receptor
|
1.9E-02 |
0.324 |
0.923 |
| CD44 |
P16070
|
CD44 molecule (Indian blood group)
|
|
2.4E-07 |
0.363 |
0.962 |
| CD47 |
Q08722
|
CD47 molecule
|
|
0.92 |
0.468 |
0.769 |
| CDK4 |
P11802
|
cyclin dependent kinase 4
|
Kinase
|
6.3E-02 |
0.412 |
0.808 |
| CDK9 |
P50750
|
cyclin dependent kinase 9
|
Kinase
|
8.9E-05 |
0.498 |
0.769 |
| CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
| CDKN2B |
P42772
|
cyclin dependent kinase inhibitor 2B
|
|
7.3E-03 |
0.417 |
0.769 |
| COX5A |
P20674
|
cytochrome c oxidase subunit 5A
|
Enzyme
|
0.49 |
0.515 |
0.846 |
| COX8A |
P10176
|
cytochrome c oxidase subunit 8A
|
Enzyme
|
0.12 |
0.400 |
0.846 |
| CPOX |
P36551
|
coproporphyrinogen oxidase
|
Enzyme
|
0.17 |
0.488 |
0.846 |